MTOR and major depressive disorder: Among cellular pathways affected in the pathophysiology of depression, we can name the mammalian target of rapamycin (mTOR), mitogen-activated protein kinases (MAPK) or glycogen synthase kinase 3 (GSK-3), as discussed.